Butyl 3,4-dihydroxy-2-(hydroxymethyl)-5-(4-oxo-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并嘧啶类
• 英文名称: Butyl 3,4-dihydroxy-2-(hydroxymethyl)-5-(4-oxo-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate
• 英文别名: butyl 3,4-dihydroxy-2-(hydroxymethyl)-5-(4-oxo-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate
• 化学式: C₁₆H₂₂N₄O₆
• 分子量: 366.37
• InChiKey: LQYVSFYXXWXMGL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  148
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES
  申请人：Biocryst Pharmaceuticals, Inc.

  公开号：EP2919785A2

  公开（公告）日：2015-09-23
• QUINOLINE INHIBITORS OF TYROSINE KINASE
  申请人：Zhang Chengzhi

  公开号：US20110195066A1

  公开（公告）日：2011-08-11

  The present invention relates to new quinoline inhibitors of tyrosine kinases, pharmaceutical compositions thereof, and methods of use thereof.
• [EN] ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES<br/>[FR] NUCLÉOSIDES ANTIVIRAUX CONTENANT DE L'AZASUCRE
  申请人：BIOCRYST PHARM INC

  公开号：WO2014078778A2

  公开（公告）日：2014-05-22

  Disclosed are compounds comprising an azasugar attached to a heterocyclic base, including pharmaceutically acceptable salts thereof, suitable for use in inhibiting viral RNA polymerase activity or viral replication, and treating viral infections. The compounds are characterized, in part, by favorable pharmacokinetics for the active pharmaceutical ingredient, particularly in conjunction with enteral administration, including, in particular, oral administration. Also disclosed are pharmaceutical compositions comprising one or more compounds mentioned above, or pharmaceutically acceptable salts thereof, as well as methods for preparing same. Also provided are methods for inhibiting viral RNA polymerase activity, viral replication, and treating viral infections.